Arvind Sood

Arvind spent over 20 years at Amgen as a Vice President of Investor Relations, following which he became President of US operations for Innate Pharma, followed by his role as a Chief Operating Officer for Curogen, a privately held South Korean biotechnology company. Prior to Amgen, Arvind spent several years at Aventis SA (now Sanofi) in roles including Investor Relations, Financial Communications and Strategy. Prior to that, he held various commercial roles at the Upjohn Company (now Pfizer) including Sales and Marketing.

Arvind holds a Master’s in Business Administration (MBA) from Central Michigan University and a Bachelor’s in Business Administration (BBA) from Western Michigan University.